US Stock MarketDetailed Quotes

NDRA ENDRA Life Sciences

Watchlist

0.0914
+0.0043+4.94%

Close Jul 12 16:00 ET

0.0888
-0.0026-2.84%

Post 19:33 ET

6.42MMarket Cap-100P/E (TTM)

ENDRA Life Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

14.46%-2.14M

25.22%-9.55M

29.60%-2.17M

19.96%-2.6M

31.98%-2.27M

19.10%-2.51M

-14.81%-12.77M

-16.43%-3.09M

-18.21%-3.25M

-19.13%-3.33M

Net income from continuing operations

5.68%-2.78M

23.67%-10.06M

55.63%-1.46M

9.87%-3.1M

28.79%-2.56M

-2.96%-2.94M

-17.34%-13.18M

-5.96%-3.29M

-29.42%-3.44M

-12.25%-3.59M

Depreciation and amortization

-21.63%55.68K

17.58%275.45K

-9.62%61.25K

20.24%70.45K

30.59%72.71K

36.05%71.04K

4.39%234.26K

26.27%67.77K

-4.74%58.59K

-7.76%55.68K

Change In working capital

-16.39%106.67K

9.99%-923.32K

-648.17%-1.19M

202.59%178.89K

63.92%-40.03K

121.94%127.58K

18.68%-1.03M

-580.19%-159.02K

63.51%-174.38K

-4,557.37%-110.94K

-Change in inventory

-155.75%-231.79K

91.46%-116.19K

69.20%-3.28K

--0

94.99%-22.28K

85.96%-90.63K

-95.72%-1.36M

-104.95%-10.64K

-48.24%-259.35K

25.70%-444.47K

-Change in prepaid assets

-67.72%42.61K

-52.87%167.36K

258.98%124.98K

208.93%86.49K

-177.74%-176.11K

-53.94%132K

137.10%355.13K

53.97%-78.61K

61.88%-79.4K

217.48%226.54K

-Change in payables and accrued expense

175.15%337.71K

-836.96%-822.26K

-3,524.36%-1.27M

-33.85%130.8K

40.34%195.81K

164.40%122.74K

-77.28%111.58K

6.92%-35.09K

400.80%197.73K

-82.94%139.53K

-Change in other current liabilities

-14.58%-41.86K

-15.04%-152.23K

-14.91%-39.85K

-15.08%-38.39K

-15.09%-37.45K

-15.08%-36.53K

-31.88%-132.33K

-15.42%-34.68K

-15.61%-33.36K

-32.49%-32.54K

Cash from discontinued investing activities

Operating cash flow

14.46%-2.14M

25.22%-9.55M

29.60%-2.17M

19.96%-2.6M

31.98%-2.27M

19.10%-2.51M

-14.81%-12.77M

-16.43%-3.09M

-18.21%-3.25M

-19.13%-3.33M

Investing cash flow

Cash flow from continuing investing activities

11.87%-23.8K

87.80%-24.72K

105.91%2.28K

69.78%-27K

-350.17%-202.58K

-38.56K

-14.86K

-59.8K

Net PPE purchase and sale

11.87%-23.8K

87.80%-24.72K

105.91%2.28K

--0

69.78%-27K

-350.17%-202.58K

---38.56K

---14.86K

---59.8K

Cash from discontinued investing activities

Investing cash flow

11.87%-23.8K

87.80%-24.72K

105.91%2.28K

--0

69.78%-27K

-350.17%-202.58K

---38.56K

---14.86K

---59.8K

Financing cash flow

Cash flow from continuing financing activities

468.9K

-10.49%7.52M

1.67M

1.11M

-37.28%4.73M

-37.32%8.4M

7.55M

Net issuance payments of debt

---28.48K

----

--0

----

Net common stock issuance

--419.97K

-22.81%6.48M

--656.81K

--1.11M

-37.54%4.71M

--0

-20.88%8.4M

--0

--7.55M

Proceeds from stock option exercised by employees

--77.42K

--1.03M

--1.01M

--0

--20.05K

--0

----

Cash from discontinued financing activities

Financing cash flow

--468.9K

-10.49%7.52M

--1.67M

--1.11M

-37.28%4.73M

--0

-37.32%8.4M

--0

--7.55M

Net cash flow

Beginning cash position

-42.04%2.83M

-48.33%4.89M

-58.40%3.33M

-57.27%4.82M

-66.95%2.36M

-48.33%4.89M

30.91%9.46M

-32.03%8.02M

-19.69%11.28M

-57.68%7.13M

Current changes in cash

32.94%-1.7M

55.05%-2.06M

83.99%-500.63K

54.47%-1.48M

-40.63%2.46M

-8.55%-2.53M

-304.65%-4.57M

-34.12%-3.13M

-44.95%-3.26M

248.27%4.15M

End cash Position

-51.82%1.13M

-42.04%2.83M

-58.40%3.33M

-57.27%4.82M

-66.95%2.36M

-48.33%4.89M

-32.03%8.02M

-19.69%11.28M

Free cash flow

14.31%-2.17M

26.13%-9.58M

30.24%-2.18M

20.32%-2.6M

33.17%-2.27M

20.52%-2.53M

-16.16%-12.97M

-17.89%-3.13M

-18.75%-3.26M

-21.27%-3.39M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	14.46%-2.14M	25.22%-9.55M	29.60%-2.17M	19.96%-2.6M	31.98%-2.27M	19.10%-2.51M	-14.81%-12.77M	-16.43%-3.09M	-18.21%-3.25M	-19.13%-3.33M
Net income from continuing operations	5.68%-2.78M	23.67%-10.06M	55.63%-1.46M	9.87%-3.1M	28.79%-2.56M	-2.96%-2.94M	-17.34%-13.18M	-5.96%-3.29M	-29.42%-3.44M	-12.25%-3.59M
Depreciation and amortization	-21.63%55.68K	17.58%275.45K	-9.62%61.25K	20.24%70.45K	30.59%72.71K	36.05%71.04K	4.39%234.26K	26.27%67.77K	-4.74%58.59K	-7.76%55.68K
Change In working capital	-16.39%106.67K	9.99%-923.32K	-648.17%-1.19M	202.59%178.89K	63.92%-40.03K	121.94%127.58K	18.68%-1.03M	-580.19%-159.02K	63.51%-174.38K	-4,557.37%-110.94K
-Change in inventory	-155.75%-231.79K	91.46%-116.19K	69.20%-3.28K	--0	94.99%-22.28K	85.96%-90.63K	-95.72%-1.36M	-104.95%-10.64K	-48.24%-259.35K	25.70%-444.47K
-Change in prepaid assets	-67.72%42.61K	-52.87%167.36K	258.98%124.98K	208.93%86.49K	-177.74%-176.11K	-53.94%132K	137.10%355.13K	53.97%-78.61K	61.88%-79.4K	217.48%226.54K
-Change in payables and accrued expense	175.15%337.71K	-836.96%-822.26K	-3,524.36%-1.27M	-33.85%130.8K	40.34%195.81K	164.40%122.74K	-77.28%111.58K	6.92%-35.09K	400.80%197.73K	-82.94%139.53K
-Change in other current liabilities	-14.58%-41.86K	-15.04%-152.23K	-14.91%-39.85K	-15.08%-38.39K	-15.09%-37.45K	-15.08%-36.53K	-31.88%-132.33K	-15.42%-34.68K	-15.61%-33.36K	-32.49%-32.54K
Cash from discontinued investing activities
Operating cash flow	14.46%-2.14M	25.22%-9.55M	29.60%-2.17M	19.96%-2.6M	31.98%-2.27M	19.10%-2.51M	-14.81%-12.77M	-16.43%-3.09M	-18.21%-3.25M	-19.13%-3.33M
Investing cash flow
Cash flow from continuing investing activities	11.87%-23.8K	87.80%-24.72K	105.91%2.28K	0	0	69.78%-27K	-350.17%-202.58K	-38.56K	-14.86K	-59.8K
Net PPE purchase and sale	11.87%-23.8K	87.80%-24.72K	105.91%2.28K	--0	--0	69.78%-27K	-350.17%-202.58K	---38.56K	---14.86K	---59.8K
Cash from discontinued investing activities
Investing cash flow	11.87%-23.8K	87.80%-24.72K	105.91%2.28K	--0	--0	69.78%-27K	-350.17%-202.58K	---38.56K	---14.86K	---59.8K
Financing cash flow
Cash flow from continuing financing activities	468.9K	-10.49%7.52M	1.67M	1.11M	-37.28%4.73M	0	-37.32%8.4M	0	0	7.55M
Net issuance payments of debt	---28.48K	----	----	----	----	--0	----	----	----	----
Net common stock issuance	--419.97K	-22.81%6.48M	--656.81K	--1.11M	-37.54%4.71M	--0	-20.88%8.4M	--0	--0	--7.55M
Proceeds from stock option exercised by employees	--77.42K	--1.03M	--1.01M	--0	--20.05K	--0	--0	--0	--0	----
Cash from discontinued financing activities
Financing cash flow	--468.9K	-10.49%7.52M	--1.67M	--1.11M	-37.28%4.73M	--0	-37.32%8.4M	--0	--0	--7.55M
Net cash flow
Beginning cash position	-42.04%2.83M	-48.33%4.89M	-58.40%3.33M	-57.27%4.82M	-66.95%2.36M	-48.33%4.89M	30.91%9.46M	-32.03%8.02M	-19.69%11.28M	-57.68%7.13M
Current changes in cash	32.94%-1.7M	55.05%-2.06M	83.99%-500.63K	54.47%-1.48M	-40.63%2.46M	-8.55%-2.53M	-304.65%-4.57M	-34.12%-3.13M	-44.95%-3.26M	248.27%4.15M
End cash Position	-51.82%1.13M	-42.04%2.83M	-42.04%2.83M	-58.40%3.33M	-57.27%4.82M	-66.95%2.36M	-48.33%4.89M	-48.33%4.89M	-32.03%8.02M	-19.69%11.28M
Free cash flow	14.31%-2.17M	26.13%-9.58M	30.24%-2.18M	20.32%-2.6M	33.17%-2.27M	20.52%-2.53M	-16.16%-12.97M	-17.89%-3.13M	-18.75%-3.26M	-21.27%-3.39M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall